Volume 22, Issue 1 pp. 7-13
Article
Full Access

T lymphocyte adhesion to the fibronectin and laminin components of the extracellular matrix is regulated by the CD4 molecule

Rami Hershkoviz

Rami Hershkoviz

Department of Cell Biology, Brigham and Women's Hospital, Harvard Medical School, Boston

Recipient of the Israeli Ministry of Health fellowship.

Search for more papers by this author
Shmuel Miron

Shmuel Miron

Department of Cell Biology, Brigham and Women's Hospital, Harvard Medical School, Boston

Search for more papers by this author
Iran R. Cohen

Iran R. Cohen

Department of Cell Biology, Brigham and Women's Hospital, Harvard Medical School, Boston

Search for more papers by this author
Ariel Miller

Ariel Miller

The Weizmann Institute of Science, Rehovot, and Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston

Recipient of the Fogarti International Fellowship (NIH).

Search for more papers by this author
Ofer Lider

Corresponding Author

Ofer Lider

Department of Cell Biology, Brigham and Women's Hospital, Harvard Medical School, Boston

Incumbant of the Weizmann Legue Career Development Chair in Children's Diseases.

The Department of Cell Biology, The Weizmann Institute of Science, P.O. Box. 26, Rehovot 76100, IsraelSearch for more papers by this author
First published: January 1992
Citations: 13

Abstract

The adhesion of T cells to components of the extracellular matrix (ECM) is mediated by the β1 subfamily of integrin receptors, designated VLA. It has been recently demonstrated that the binding of VLA receptors to protein components of the ECM is rapidly augmented by the activation of the T cells without, however, any actual change in the level of expression of the VLA receptors for fibronectin (FN) or laminin (LN). Thus, it is likely that activation of existing VLA receptors is required for binding. The activation must be regulated by T cell surface molecules capable of transducing signals into the cell. We studied the role of the CD4 molecule in the binding of rat CD4+ T cells to the FN and LN components of the ECM. We now report that the CD4 molecule appears to play a major role in regulating T cell interactions with ECM. This conclusion is based on the following observations: (a) monoclonal antibodies directed against the CD4 molecule inhibited T cell adhesion to both FN and LN; (b) down-regulation of the CD4 molecule resulted in partial loss of the ability of CD4+ T cells to adhere to FN and LN; (c) a CD4+ T cell clone adhered to both FN and LN while a CD4CD8 clone expressing an identical T cell receptor bound weakly to both proteins and (d) treatment of the CD4+ T cells with an inhibitor of the CD4-associated tyrosine protein kinase activity inhibited T cell adhesion to both ECM proteins.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.